Is there a gender-related susceptibility for cisplatin ototoxicity?
about
Cisplatin-Associated Ototoxicity: A Review for the Health ProfessionalProphylactic etanercept treatment in cisplatin ototoxicity.Promoter region variation in NFE2L2 influences susceptibility to ototoxicity in patients exposed to high cumulative doses of cisplatin.COAST (Cisplatin ototoxicity attenuated by aspirin trial): A phase II double-blind, randomised controlled trial to establish if aspirin reduces cisplatin induced hearing-loss.
P2860
Is there a gender-related susceptibility for cisplatin ototoxicity?
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Is there a gender-related susceptibility for cisplatin ototoxicity?
@en
Is there a gender-related susceptibility for cisplatin ototoxicity?
@nl
type
label
Is there a gender-related susceptibility for cisplatin ototoxicity?
@en
Is there a gender-related susceptibility for cisplatin ototoxicity?
@nl
prefLabel
Is there a gender-related susceptibility for cisplatin ototoxicity?
@en
Is there a gender-related susceptibility for cisplatin ototoxicity?
@nl
P2093
P2860
P1476
Is there a gender-related susceptibility for cisplatin ototoxicity?
@en
P2093
Efsun Kolatan
Günay Kirkim
Hülya Ellidokuz
Müge Kiray
Osman Yilmaz
Pınar Erçetin
Safiye Aktas
Yüksel Olgun
P2860
P2888
P304
P356
10.1007/S00405-014-3283-0
P577
2014-09-12T00:00:00Z